Skip to main content

Investigating Pharmacology In Vivo Using Magnetic Resonance and Optical Imaging

Drugs in R & D volume 9, pages 277–306 (2008)Cite this article

Abstract

The better and earlier a disease can be diagnosed and characterized, the greater the chance of being able to intervene in this process with a chemical entity. This is the rationale for the use of in vivo imaging techniques in the drug discovery and development process. In this article we address the value of two imaging modalities in this area, i.e. magnetic resonance imaging (MRI) and optical imaging. The multiparametric nature of MRI enables anatomical, functional, metabolic and, to a certain extent, also cellular and target-related information to be obtained noninvasively at high spatial resolution. This favours characterization of a disease state and the corresponding drug intervention. The noninvasiveness of MRI strengthens the link between preclinical and clinical pharmaceutical research. The high sensitivity of optical techniques enables molecular information to be obtained in vivo. Within pharmacological research, the main applications of optical techniques relate to the early drug discovery process and acquisition of target-related information. However, potential clinical applications of optical imaging are also emerging. The complementary character of both imaging modalities renders them useful in various portions of the drug discovery process, from early target selection and validation to clinical studies.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

49,54 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Table I
Table II
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

References

  1. Hargreaves R, Wagner JA. Imaging as biomarker for decision making in drug development. In: Beckmann N, editor. In vivo MR techniques in drug discovery and development. New York (NY): Taylor & Francis, 2006: 31–44

    Google Scholar 

  2. Frank R, Hargreaves R. Clinical biomarkers in drug discovery and development. Nat Rev Drug Discov 2003 Jul; 2 (7): 566–80

    PubMed  CAS  Article  Google Scholar 

  3. Colburn WA. Biomarkers in drug discovery and development: from target identification through drug marketing. J Clin Pharmacol 2003 Apr; 43 (4): 329–41

    PubMed  Article  Google Scholar 

  4. DiMasi JA, Paquette C. The economics of follow-on drug research and development: trends in entry rates and the timing of development. Pharmacoeconomics 2004; 22 (2 Suppl. 2): 1–14

    PubMed  Article  Google Scholar 

  5. Duyk G. Attrition and translation. Science 2003 Oct; 302 (5645): 603–5

    PubMed  CAS  Article  Google Scholar 

  6. Horig H, Pullman W. From bench to clinic and back: perspective on the 1st IQPC Translational Research conference. J Transl Med 2004 Dec; 2 (1): 44

    PubMed  Article  Google Scholar 

  7. Knowles J, Gromo G. A guide to drug discovery: target selection in drug discovery. Nat Rev Drug Discov 2004 Jan; 2 (1): 63–9

    Article  CAS  Google Scholar 

  8. Stein RL. A new model for drug discovery: meeting our societal obligation. Drug Discov Today 2003 Mar; 8 (6): 245–8

    PubMed  Article  Google Scholar 

  9. Beckmann N, Tigani B, Laurent D, et al. Magnetic resonance imaging in drug discovery: lessons from disease areas. Drug Discov Today 2004 Jan; 9 (1): 35–42

    PubMed  CAS  Article  Google Scholar 

  10. Beckmann N, editor. In vivo MR techniques in drug discovery and development. New York (NY): Taylor & Francis, 2006

    Google Scholar 

  11. Rudin M, Beckmann N, Porszasz R, et al. In vivo magnetic resonance methods in pharmaceutical research: current status and perspectives. NMR Biomed 1999 Apr; 12 (2): 69–97

    PubMed  CAS  Article  Google Scholar 

  12. Rudin M, Weissleder R. Molecular imaging in drug discovery and development. Nat Rev Drug Discov 2003 Feb; 2 (2): 123–31

    PubMed  CAS  Article  Google Scholar 

  13. Beckmann N, Cannet C, Zurbruegg S, et al. Macrophage infiltration in rat kidney allografts detected by MRI: early marker of chronic rejection that strongly correlates with histology. Radiology 2006 Sep; 240 (3): 717–24

    PubMed  Article  Google Scholar 

  14. Massoud TF, Gambhir SS. Integrating noninvasive molecular imaging into molecular medicine: an evolving paradigm. Trends Mol Med 2007 May; 13 (5): 183–91

    PubMed  CAS  Article  Google Scholar 

  15. Hamstra DA, Lee KC, Tychewicz JM, et al. The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies. Mol Ther 2004 Nov; 10 (5): 916–28

    PubMed  CAS  Article  Google Scholar 

  16. Kamm YJ, Heerschap A, van den Bergh EJ, et al. 19F-magnetic resonance spectroscopy in patients with liver metastases of colorectal cancer treated with 5-fluorouracil. Anticancer Drugs 2004 Mar; 15 (3): 229–33

    PubMed  CAS  Article  Google Scholar 

  17. Klomp DW, Van Laarhoven HW, Kentgens AP, et al. Optimization of localized 19F magnetic resonance spectroscopy for the detection of fluorinated drugs in the human liver. Magn Reson Med 2003 Aug; 50 (2): 303–8

    PubMed  CAS  Article  Google Scholar 

  18. van Laarhoven HW, Klomp DW, Kamm YJ, et al. In vivo monitoring of capecitabine metabolism in human liver by 19fluorine magnetic resonance spectroscopy at 1.5 and 3 Tesla field strength. Cancer Res 2003 Nov 15; 63 (22): 7609–12

    PubMed  Google Scholar 

  19. Artemov D, Solaiyappan M, Bhujwalla ZM. Magnetic resonance pharmacoangiography to detect and predict chemotherapy delivery to solid tumors. Cancer Res 2001 Apr; 61 (7): 3039–44

    PubMed  CAS  Google Scholar 

  20. Griffiths JR, Glickson JD. Monitoring pharmacokinetics of anticancer drugs: non-invasive investigation using magnetic resonance spectroscopy. Adv Drug Deliv Rev 2000 Mar; 41 (1): 75–89

    PubMed  CAS  Article  Google Scholar 

  21. Beckmann N, Mueggler T, Allegrini PR, et al. From anatomy to the target: contributions of magnetic resonance imaging to preclinical pharmaceutical research. Anat Rec 2001 Apr; 265 (2): 85–100

    PubMed  CAS  Article  Google Scholar 

  22. Aime S, Carrera C, Delli Castelli D, et al. Tunable imaging of cells labeled with MRI-PARACEST agents. Angew Chem Int Ed Engl 2005 Mar; 44 (12): 1813–5

    PubMed  CAS  Article  Google Scholar 

  23. Aime S, Delli Castelli D, Terreno E. Highly sensitive MRI chemical exchange saturation transfer agents using liposomes. Angew Chem Int Ed Engl 2005 Aug; 44 (34): 5513–5

    PubMed  CAS  Article  Google Scholar 

  24. Woods M, Woessner DE, Sherry AD. Paramagnetic lanthanide complexes as PARACEST agents for medical imaging. Chem Soc Rev 2006 Jun; 35 (6): 500–11

    PubMed  CAS  Article  Google Scholar 

  25. Zhou J, Payen JF, Wilson DA, et al. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 2003 Aug; 9 (8): 1085–90

    PubMed  CAS  Article  Google Scholar 

  26. Cunningham CH, Arai T, Yang PC, et al. Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med 2005; May; 53 (5): 999–1005

    PubMed  CAS  Article  Google Scholar 

  27. Mani V, Briley-Saebo KC, Itskovich VV, et al. Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T. Magn Reson Med 2006 Jan; 55 (1): 126–35

    PubMed  CAS  Article  Google Scholar 

  28. Månsson S, Johansson E, Magnusson P, et al. 13C imaging: a new diagnostic platform. Eur Radiol 2006 Jan; 16 (1): 57–67

    PubMed  Article  Google Scholar 

  29. Möller HE, Chen XJ, Saam B, et al. MRI of the lungs using hyperpolarized noble gases. Magn Reson Med 2002 Jun; 47 (6): 1029–51

    PubMed  Article  Google Scholar 

  30. Patz S, Hersman FW, Muradian I, et al. Hyperpolarized (129)Xe MRI: a viable functional lung imaging modality? Eur J Radiol 2007 Dec; 64 (3): 335–44

    PubMed  Article  Google Scholar 

  31. Contag CH, Spilman SD, Contag PR, et al. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 1997 Oct; 66 (4): 523–31

    PubMed  CAS  Article  Google Scholar 

  32. Zhang W, Feng JQ, Harris SE, et al. Rapid in vivo functional analysis of transgenes in mice using whole body imaging of luciferase expression. Transgenic Res 2001 Oct; 10 (5): 423–34

    PubMed  CAS  Article  Google Scholar 

  33. Rice BW, Cable MD, Nelson MB. In vivo imaging of lightspectroscopy emitting probes. J Biomed Opt 2001 Oct; 6 (4): 432–40

    PubMed  CAS  Article  Google Scholar 

  34. Choy G, Choyke P, Libutti SK. Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research. Mol Imaging 2003 Oct; 2 (4): 303–12

    PubMed  CAS  Article  Google Scholar 

  35. Piwnica-Worms D, Schuster DP, Garbow JR. Molecular imaging of host-pathogen interactions in intact small animals. Cell Microbiol 2004 Apr; 6 (4): 319–31

    PubMed  CAS  Article  Google Scholar 

  36. Wang G, Li Y, Jiang M. Uniqueness theorems in biolumines cence tomography. Med Phys 2004 Aug; 31 (8): 2289–99

    PubMed  Article  Google Scholar 

  37. Ntziachristos V, Ripoll J, Wang LV, et al. Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol 2005 Mar; 23 (3): 313–20

    PubMed  CAS  Article  Google Scholar 

  38. Patwardhan SV, Bloch S, Achilefu S, et al. Quantitative small animal fluorescence tomography using an ultrafast gated image intensifier. Conf Proc IEEE Eng Med Biol Soc 2006; 1: 2675–8

    PubMed  Google Scholar 

  39. Zacharakis G, Kambara H, Shih H, et al. Volumetric tomography of fluorescent proteins through small animals in vivo. Proc Natl Acad Sci USA 2005 Dec; 102 (51): 18252–7

    PubMed  CAS  Article  Google Scholar 

  40. Ntziachristos V, Tung CH, Bremer C, et al. Fluorescence molecular ular tomography resolves protease activity in vivo. Nat Med 2002 Jul; 8 (7): 757–60

    PubMed  CAS  Article  Google Scholar 

  41. Ntziachristos V, Ripoll J, Weissleder R. Would near-infrared fluorescence signals propagate through large human organs for clinical studies? Opt Lett 2002 Mar; 27 (5): 333–5

    PubMed  Article  Google Scholar 

  42. Ripoll J, Schulz RB, Ntziachristos V. Free-space propagation of diffuse light: theory and experiments. Phys Rev Lett 2003 Sep; 91 (10): 103901–4

    PubMed  Article  CAS  Google Scholar 

  43. Schulz RB, Ripoll J, Ntziachristos V. Experimental fluorescence tomography of tissues with noncontact measurements. molecuIEEE Trans Med Imaging 2004 Apr; 23 (4): 492–500

    Article  Google Scholar 

  44. Garofalakis A, Zacharakis G, Meyer H, et al. Three-dimensional in vivo imaging of green fluorescent protein-expressing T cells in mice with noncontact fluorescence molecular tomography. Mol Imaging 2007 Mar-Apr; 6 (2): 96–107

    PubMed  Google Scholar 

  45. Lasser T, Ntziachristos V. Optimization of 360 degrees projection fluorescence molecular tomography. Med Image Anal 2007 Aug; 11 (4): 389–99

    PubMed  Article  Google Scholar 

  46. Jain RK, Munn LL, Fukumura D. Dissecting tumour pathophysiology using intravital microscopy. Nat Rev Cancer 2002 Apr; 2 (4): 266–76

    PubMed  CAS  Article  Google Scholar 

  47. Nombela-Arrieta C, Lacalle RA, Montoya MC, et al. Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing. Immunity 2004 Sep; 21 (3): 429–41

    PubMed  CAS  Article  Google Scholar 

  48. Hoffman RM. The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer 2005 Oct; 5 (10): 796–806

    PubMed  CAS  Article  Google Scholar 

  49. Hoffman RM. Whole-body fluorescence imaging with green fluorescence protein. Methods Mol Biol 2002; 183: 135–48

    PubMed  CAS  Google Scholar 

  50. Shaner NC, Campbell RE, Steinbach PA, et al. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent proteins. Nat Biotechnol 2004 Dec; 22 (12): 1567–72

    PubMed  CAS  Article  Google Scholar 

  51. Shcherbo D, Merzlyak EM, Chepurnykh TV, et al. Bright farred fluorescent protein for whole-body imaging. Nat Methods 2007 Sep; 4 (9): 741–6

    PubMed  CAS  Article  Google Scholar 

  52. Slates RB, Farahani K, Shao Y, et al. A study of artefacts in simultaneous PET and MR imaging using a prototype MR compatible PET scanner. Phys Med Biol 1999 Aug; 44 (8): 2015–27

    PubMed  CAS  Article  Google Scholar 

  53. Benveniste H, Fowler JS, Rooney W, et al. Maternal and fetal 11C-cocaine uptake and kinetics measured in vivo by combined PET and MRI in pregnant nonhuman primates. J Nucl Med 2005 Feb; 46 (2): 312–20

    PubMed  CAS  Google Scholar 

  54. Del Guerra A, Belcari N. Advances in animal PET scanners. Q J Nucl Med 2002 Mar; 46 (1): 35–47

    PubMed  Google Scholar 

  55. Fahey FH. Instrumentation in positron emission tomography. Neuroimaging Clin N Am 2003 Nov; 13 (4): 659–69

    PubMed  Article  Google Scholar 

  56. Ntziachristos V, Yodh AG, Schnall M, et al. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci U S A 2000 Mar; 97 (6): 2767–72

    PubMed  CAS  Article  Google Scholar 

  57. Phelps ME. Positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci U S A 2000 Aug; 97 (16): 9226–33

    PubMed  CAS  Article  Google Scholar 

  58. Fischman AJ, Alpert NM, Rubin RH. Pharmacokinetic imaging: a noninvasive method for determining drug distribution and action. Clin Pharmacokinet 2002; 41 (8): 581–602

    PubMed  CAS  Article  Google Scholar 

  59. Sipkins DA, Cheresh DA, Kazemi MR, et al. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med 1998 May; 4 (5): 623–6

    PubMed  CAS  Article  Google Scholar 

  60. Weissleder R, Moore A, Mahmood U, et al. In vivo magnetic resonance imaging of transgene expression. Nat Med 2000 Mar; 6 (3): 351–5

    PubMed  CAS  Article  Google Scholar 

  61. Hogemann D, Ntziachristos V, Josephson L, et al. High throughput magnetic resonance imaging for evaluating targeted nanoparticle probes. Bioconjug Chem 2002 Jan–Feb; 13 (1): 116–21

    PubMed  Article  CAS  Google Scholar 

  62. Bornhop DJ, Contag CH, Licha K, et al. Advance in contrast agents, reporters, and detection. J Biomed Opt 2001 Apr; 6 (2): 106–10

    PubMed  CAS  Article  Google Scholar 

  63. Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med 2003 Jan; 9 (1): 123–8

    PubMed  CAS  Article  Google Scholar 

  64. Tung CH, Mahmood U, Bredow S, et al. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res 2000 Sep; 60 (17): 4953–8

    PubMed  CAS  Google Scholar 

  65. Louie AY, Huber MM, Ahrens ET, et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotion technol 2000 Mar; 18 (3): 321–5

    CAS  Google Scholar 

  66. Perez JM, Josephson L, O’Loughlin T, et al. Magnetic relaxation switches capable of sensing molecular interactions, Nat Biotechnol 2002 Aug; 20 (8): 816–20

    PubMed  CAS  Google Scholar 

  67. Lanza GM, Winter P, Caruthers S, et al. Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery. Curr Pharm Biotech 2004 Dec; 5 (6): 495–507

    CAS  Article  Google Scholar 

  68. Morawski AM, Lanza GA, Wickline SA. Targeted contrast agents for magnetic resonance imaging and ultrasound. Curr Opin Biotechnol 2005 Feb; 16 (1): 89–92

    PubMed  CAS  Article  Google Scholar 

  69. Mulder WJ, Douma K, Koning GA, et al. Liposome-enhanced MRI of neointimal lesions in the ApoE-KO mouse. Magn Reson Med 2006 May; 55 (5): 1170–4

    PubMed  Article  Google Scholar 

  70. Licha K. Contrast agents for optical imaging. Top Curr Chem 2002; 222: 1–29

    CAS  Article  Google Scholar 

  71. Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003 Oct; 7 (5): 626–34

    PubMed  CAS  Article  Google Scholar 

  72. Funovics M, Weissleder R, Tung CH. Protease sensors for bioimaging. Anal Bioanal Chem 2003 Nov; 377 (6): 956–63

    PubMed  CAS  Article  Google Scholar 

  73. Ballou B, Lagerholm BC, Ernst LA, et al. Noninvasive imaging of quantum dots in mice. Bioconjugate Chem 2004 Jan–Feb; 15 (1): 79–86

    CAS  Article  Google Scholar 

  74. Gao X, Cui Y, Levenson RM, et al. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004 Aug; 22 (8): 969–76

    PubMed  CAS  Article  Google Scholar 

  75. Portney NG, Ozkan M. Nano-oncology: drug delivery, imaging, and sensing. Anal Bioanal Chem 2006 Feb; 384 (3): 620–30

    PubMed  CAS  Article  Google Scholar 

  76. Doubrovin M, Serganova I, Mayer-Kuckuk P, et al. Multimodality in vivo molecular-genetic imaging. Bioconjug Chem 2004 Nov-Dec; 15 (6): 1376–88

    PubMed  CAS  Article  Google Scholar 

  77. Kircher MF, Mahmood U, King RS, et al. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 2003 Dec; 63 (23): 8122–5

    PubMed  CAS  Google Scholar 

  78. Uzgiris EE, Sood A, Bove K, et al. A multimodal contrast agent for preoperative MR imaging and intraoperative tumor margin delineation. Technol Cancer Res Treat 2006 Aug; 5 (4): 301–9

    PubMed  CAS  Google Scholar 

  79. Josephson L, Kircher MF, Mahmood U, et al. Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug Chem 2002 May-Jun; 13 (3): 554–60

    PubMed  CAS  Article  Google Scholar 

  80. Jaffer FA, Nahrendorf M, Sosnovik D, et al. Cellular imaging of inflammation in atherosclerosis using magnetofluorescent nanomaterials. Mol Imaging 2006 Apr-Jun; 5 (2): 85–92

    PubMed  Google Scholar 

  81. Nahrendorf M, Jaffer FA, Kelly KA, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006 Oct; 114 (14): 1504–11

    PubMed  CAS  Article  Google Scholar 

  82. Jaffer FA, Weissleder R. Molecular imaging in the clinical arena. JAMA 2005 Feb; 293 (7): 855–62

    PubMed  CAS  Article  Google Scholar 

  83. Dodd SJ, Ho C. Short planar gradient coils for MR microscopy using concentric return paths. J Magn Reson 2002 May; 156 (1): 1–9

    PubMed  CAS  Article  Google Scholar 

  84. Leggett J, Crozier S, Bowtell RW. Actively shielded multilayer gradient coil designs with improved cooling properties. J Magn Reson 2003 Dec; 165 (2): 196–207

    PubMed  CAS  Article  Google Scholar 

  85. Webb AG. Radiofrequency microcoils in magnetic resonance. Progr Nucl Magn Reson Spectrosc 1997; 31: 1–42

    CAS  Article  Google Scholar 

  86. Bilgen M. Inductively-overcoupled coil design for high resolution magnetic resonance imaging. Biomed Eng Online 2006 Jan 9; 5: 3

    PubMed  Article  Google Scholar 

  87. Darrasse L, Ginefri JC. Perspectives with cryogenic RF probes in biomedical MRI. Biochimie 2003 Sep; 85 (9): 915–37

    PubMed  CAS  Article  Google Scholar 

  88. Voehler MW, Collier G, Young JK, et al. Performance of cryogenic probes as a function of ionic strength and sample tube geometry. J Magn Reson 2006 Nov; 183 (1): 102–9

    PubMed  CAS  Article  Google Scholar 

  89. Hedlund LW, Cofer GP, Owen SJ, et al. MR-compatible ventilator for small animals: computer-controlled ventilation for proton and noble gas imaging. Magn Reson Imaging 2000 Jul; 18 (6): 753–9

    PubMed  CAS  Article  Google Scholar 

  90. Brau AC, Hedlund LW, Johnson GA. Cine magnetic resonance microscopy of the rat heart using cardiorespiratory-synchronous projection reconstruction. J Magn Reson Imaging 2004 Jul; 20 (1): 31–8

    PubMed  Article  Google Scholar 

  91. Srinivasan S, Pogue BW, Jiang S, et al. Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography. Proc Natl Acad Sci U S A 2003 Oct; 100 (21): 12349–54

    PubMed  CAS  Article  Google Scholar 

  92. Srinivasan S, Pogue BW, Jiang S, et al. In vivo hemoglobin and water concentrations, oxygen saturation, and scattering estimates from near-infrared breast tomography using spectral reconstruction. Acad Radiol 2006 Feb; 13 (2): 195–202

    PubMed  Article  Google Scholar 

  93. Boverman G, Fang Q, Carp SA, et al. Spatio-temporal imaging of the hemoglobin in the compressed breast with diffuse optical tomography. Phys Med Biol 2007 Jun; 52 (12): 3619–41

    PubMed  CAS  Article  Google Scholar 

  94. Brooksby B, Pogue BW, Jiang S, et al. Imaging breast adipose and fibroglandular tissue molecular signatures by using hybrid MRI-guided near-infrared spectral tomography. Proc Natl Acad Sci U S A 2006 Jun; 103 (23): 8828–33

    PubMed  CAS  Article  Google Scholar 

  95. Dehghani H, Pogue BW, Poplack SP, et al. Multiwavelength three-dimensional near-infrared tomography of the breast: initial simulation, phantom, and clinical results. Appl Opt 2003 Jan; 42 (1): 135–45

    PubMed  Article  Google Scholar 

  96. Intes X, Ripoll J, Chen Y, et al. In vivo continuous-wave optical breast imaging enhanced with indocyanine green. Med Phys 2003 Jun; 30 (6): 1039–47

    PubMed  Article  Google Scholar 

  97. Choe R, Corlu A, Lee K, et al. Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI. Med Phys 2005 Apr; 32 (4): 1128–39

    PubMed  Article  Google Scholar 

  98. Benaron DA, Hintz SR, Villringer A, et al. Noninvasive functional imaging of human brain using light. J Cereb Blood Flow Metab 2000 Mar; 20 (3): 469–77

    PubMed  CAS  Article  Google Scholar 

  99. Hillman EM, Hebden JC, Schweiger M, et al. Time resolved optical tomography of the human forearm. Phys Med Biol 2001 Apr; 46 (4): 1117–30

    PubMed  CAS  Article  Google Scholar 

  100. Hampel U, Schleicher E, Freyer R. Volume image reconstruction for diffuse optical tomography. Appl Opt 2002 Jul; 41 (19): 3816–26

    PubMed  Article  Google Scholar 

  101. Hielscher AH, Klose AD, Scheel AK, et al. Sagittal laser optical tomography for imaging of rheumatoid finger joints. Phys Med Biol 2004 Apr; 49 (7): 1147–63

    PubMed  Article  Google Scholar 

  102. Scheel AK, Backhaus M, Klose AD, et al. First clinical evaluation of sagittal laser optical tomography for detection of synovitis in arthritic finger joints. Ann Rheum Dis 2005 Feb; 64 (2): 239–45

    PubMed  CAS  Article  Google Scholar 

  103. Bremer C, Tung CH, Weissleder R. In vivo molecular target assessment of matrix metalloproteinase inhibition, Nat Med 2001 Jun; 7 (6): 743–8

    PubMed  CAS  Article  Google Scholar 

  104. Chen JW, Querol Sans M, Bogdanov Jr A, et al. Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates. Radiology 2006 Aug; 240 (2): 473–81

    PubMed  Article  Google Scholar 

  105. Podgorski I, Sloane BF. Cathepsin B and its role(s) in cancer progression. Proceedings of the Biochemical Society Symposium, vol. 70: proteases and the regulation of biological processes. London: Portland Press, 2003: 263–76

    Google Scholar 

  106. von Wallbrunn A, Höltke C, Zühlsdorf M, et al. In vivo imaging of integrin alpha v beta 3 expression using fluorescencemediated tomography. Eur J Nucl Med Mol Imaging 2007 May; 34 (5): 745–54

    Article  CAS  Google Scholar 

  107. Hodivala-Dilke KM, Reynolds AR, Reynolds LE. Integrins in angiogenesis: multitalented molecules in a balancing act. Cell Tissue Res 2003 Oct; 314 (1): 131–44

    PubMed  CAS  Article  Google Scholar 

  108. Jin H, Varner J. Integrins: roles in cancer development and as treatment targets. Br J Cancer 2004 Feb; 90 (3): 561–5

    PubMed  CAS  Article  Google Scholar 

  109. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987 Oct; 238 (4826): 491–7

    PubMed  CAS  Article  Google Scholar 

  110. D’Souza SE, Ginsberg MH, Matsueda GR, et al. A discrete sequence in a platelet integrin is involved in ligand recognition. Nature 1991 Mar; 350 (6313): 66–8

    PubMed  Article  Google Scholar 

  111. Licha K, Riefke B, Ntziachristos V, et al. Hydrophilic cyanine dyes as contrast agents for near-infrared tumor imaging: synthesis, photophysical properties and spectroscopic in vivo characterization. Photochem Photobiol 2000 Sep; 72 (3): 392–8

    PubMed  CAS  Article  Google Scholar 

  112. Schäfer R, Wiskirchen J, Guo K, et al. Aptamer-based isolation and subsequent imaging of mesenchymal stem cells in ischemic myocard by magnetic resonance imaging. Rofo 2007 Oct; 179 (10): 1009–15

    PubMed  Article  Google Scholar 

  113. Schmieder AH, Winter PM, Caruthers SD, et al. Molecular MR imaging of melanoma angiogenesis with al-phanubeta3-targeted paramagnetic nanoparticles. Magn Reson Med 2005 Mar; 53 (3): 621–7

    PubMed  CAS  Article  Google Scholar 

  114. Winter PM, Neubauer AM, Caruthers SD, et al. Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler Thromb Vasc Biol 2006 Sep; 26 (9): 2103–9

    PubMed  CAS  Article  Google Scholar 

  115. Kelly KA, Allport JR, Tsourkas A, et al. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res 2005 Feb; 96 (3): 327–36

    PubMed  CAS  Article  Google Scholar 

  116. Karmouty-Quintana H, Cannet C, Sugar R, et al. Capsaicin-induced mucus secretion in rat airways assessed in vivo and non-invasively by magnetic resonance imaging. Br J Pharmacol 2007 Apr; 150 (8): 1022–30

    PubMed  CAS  Article  Google Scholar 

  117. Karmouty-Quintana H, Blé FX, Cannet C, et al. In vivo pharmacological evaluation of compound 48/80 induced airways oedema by MRI. Br J Pharmacol 2008 Jul; 154 (5): 1063–72

    PubMed  CAS  Article  Google Scholar 

  118. Beckmann N, Kneuer R, Gremlich HU, et al. In vivo mouse imaging and spectroscopy in drug discovery. NMR Biomed 2007 May; 20 (3): 154–85

    PubMed  Article  Google Scholar 

  119. El-Deiry WS, Sigman CC, Kelloff GJ. Imaging and oncologic drug development. J Clin Oncol 2006 Jul 10; 24 (20): 3261–73

    PubMed  CAS  Article  Google Scholar 

  120. Stephen RM, Gillies RJ. Promise and progress for functional and molecular imaging of response to targeted therapies. Pharm Res 2007 Jun; 24 (6): 1172–85

    PubMed  CAS  Article  Google Scholar 

  121. Rosen MA, Schnall MD. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma. Clin Cancer Res 2007 Jan; 13 (2 Pt 2): 770s–6s

    PubMed  CAS  Article  Google Scholar 

  122. Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2003 May; 17 (5): 509–20

    PubMed  Article  Google Scholar 

  123. Jordan BF, Runquist M, Raghunand N, et al. Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478. Neoplasia 2005 May; 7 (5): 475–85

    PubMed  CAS  Article  Google Scholar 

  124. Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol 2006 Jul; 24 (20): 3293–8

    PubMed  CAS  Article  Google Scholar 

  125. Barrett T, Brechbiel M, Bernardo M, et al. MRI of tumor angiogenesis. J Magn Reson Imaging 2007 Aug; 26 (2): 235–49

    PubMed  Article  Google Scholar 

  126. Mullamitha SA, Ton NC, Parker GJ, et al. Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors. Clin Cancer Res 2007 Apr; 13 (7): 2128–35

    PubMed  CAS  Article  Google Scholar 

  127. Drevs J, Müller-Driver R, Wittig C, et al. PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging. Cancer Res 2002 Jul; 62 (14): 4015–22

    PubMed  CAS  Google Scholar 

  128. Rudin M, McSheehy PM, Allegrini PR, et al. PTK787/ ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo. NMR Biomed 2005 Aug; 18 (5): 308–21

    PubMed  CAS  Article  Google Scholar 

  129. Nakamura K, Taguchi E, Miura T, et al. KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties. Cancer Res 2006 Sep; 66 (18): 9134–42

    PubMed  CAS  Article  Google Scholar 

  130. Salmon BA, Salmon HW, Siemann DW. Monitoring the treatment efficacy of the vascular disrupting agent CA4P. Eur J Cancer 2007 Jul; 43 (10): 1622–9

    PubMed  CAS  Article  Google Scholar 

  131. Wilmes LJ, Pallavicini MG, Fleming LM, et al. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Imaging 2007 Apr; 25 (3): 319–27

    PubMed  CAS  Article  Google Scholar 

  132. Ferrier MC, Sarin H, Fung SH, et al. Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model. Neoplasia 2007 Jul; 9 (7): 546–55

    PubMed  CAS  Article  Google Scholar 

  133. Dzik-Jurasz A, Domenig C, George M, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 2002 Jul; 360 (9329): 307–8

    PubMed  Article  Google Scholar 

  134. Theilmann RJ, Borders R, Trouard TP, et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 2004 Nov–Dec; 6 (6): 831–7

    PubMed  Article  Google Scholar 

  135. Jennings D, Hatton BN, Guo J, et al. Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. Neoplasia 2002 May–Jun; 4 (3): 255–62

    PubMed  CAS  Article  Google Scholar 

  136. Moffat BA, Hall DE, Stojanovska J, et al. Diffusion imaging for evaluation of tumor therapies in preclinical animal models. MAGMA 2004 Dec; 17 (3–6): 249–59

    PubMed  CAS  Article  Google Scholar 

  137. Pickles MD, Gibbs P, Lowry M, et al. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 2006 Sep; 24 (7): 843–7

    PubMed  Article  Google Scholar 

  138. Pogue BW, Poplack SP, McBride TO, et al. Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast. Radiology 2001 Jan; 218 (1): 261–6

    PubMed  CAS  Google Scholar 

  139. Srinivasan S, Pogue BW, Carpenter C, et al. Developments in quantitative oxygen-saturation imaging of breast tissue in vivo using multispectral near-infrared tomography. Antioxid Redox Signal 2007 Aug; 9 (8): 1143–56

    PubMed  CAS  Article  Google Scholar 

  140. Graves EE, Weissleder R, Ntziachristos V. Fluorescence molecular imaging of small animal tumor models. Curr Mol Med 2004 Jun; 4 (4): 419–30

    PubMed  CAS  Article  Google Scholar 

  141. Wessels JT, Busse AC, Mahrt J, et al. In vivo imaging in experimental preclinical tumor research: a review. Cytometry A 2007 Aug; 71 (8): 542–9

    PubMed  CAS  Google Scholar 

  142. Ntziachristos V, Schellenberger EA, Ripoll J, et al. Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc Natl Acad Sci U S A 2004 Aug; 101 (33): 12294–9

    PubMed  CAS  Article  Google Scholar 

  143. Thiele H, Nagel E, Paetsch I, et al. Functional cardiac MR imaging with steady-state free precession (SSFP) significantly improves endocardial border delineation without contrast agents. J Magn Reson Imaging 2001 Oct; 14 (4): 362–7

    PubMed  CAS  Article  Google Scholar 

  144. Kaandorp TA, Lamb HJ, Bax JJ, et al. Magnetic resonance imaging of coronary arteries, the ischemic cascade, and myocardial infarction. Am Heart J 2005 Feb; 149 (2): 200–8

    PubMed  Article  Google Scholar 

  145. Keenan NG, Pennell DJ. CMR of ventricular function. Echocardiography 2007 Feb; 24 (2): 185–93

    PubMed  Article  Google Scholar 

  146. Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Society for Cardiovascular Magnetic Resonance; Working Group on Cardiovascular Magnetic Resonance of the European Society of Cardiology. Eur Heart J 2004 Nov; 25 (21): 1940–65

    PubMed  Article  Google Scholar 

  147. Kelle S, Nagel E. Cardiac MRI techniques for clinical drug trials. In: Beckmann N, editor. In vivo MR techniques in drug discovery and development. New York (NY): Taylor and Francis, 2006: 329–47

    Google Scholar 

  148. Grothues F, Smith GC, Moon JC, et al. Comparison of inter-study reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002 Jul; 90 (1): 29–34

    PubMed  Article  Google Scholar 

  149. Bellenger NG, Davies LC, Francis JM, et al. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2000; 2 (4): 271–8

    PubMed  CAS  Article  Google Scholar 

  150. Bellenger NG, Rajappan K, Rahman SL, et al. Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study. CHRISTMAS Study Steering Committee and Investigators. Heart 2004 Jul; 90 (7): 760–4

    PubMed  CAS  Article  Google Scholar 

  151. Prasad SK, Dargie HJ, Smith GC, et al. Comparison of the dual receptor endothelin antagonist enrasentan with enalapril in asymptomatic left ventricular systolic dysfunction: a cardiovascular magnetic resonance study. Heart 2006 Jun; 92 (6): 798–803

    PubMed  CAS  Article  Google Scholar 

  152. Jahnke C, Nagel E, Gebker R, et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 2007 Apr; 115 (13): 1769–76

    PubMed  Article  Google Scholar 

  153. Vallee JP, Ivancevic MK, Nguyen D, et al. Current status of cardiac MRI in small animals. MAGMA 2004 Dec; 17 (3-6): 149–56

    PubMed  Article  Google Scholar 

  154. Nahrendorf M, Bauer WR. Cardiac MR techniques applied to small rodents. In: Beckmann N, editor. In vivo MR techniques in drug discovery and development. New York (NY): Taylor and Francis, 2006: 315–27

    Google Scholar 

  155. Wiesmann F, Ruff J, Hiller KH, et al. Developmental changes of cardiac function and mass assessed with MRI in neonatal, juvenile, and adult mice. Am J Physiol Heart Circ Physiol 2000 Feb; 278 (2): H652–7

    PubMed  CAS  Google Scholar 

  156. Wiesmann F, Frydrychowicz A, Rautenberg J, et al. Analysis of right ventricular function in healthy mice and a murine model of heart failure by in vivo MRI. Am J Physiol Heart Circ Physiol 2002 Sep; 283 (3): H1065–71

    PubMed  CAS  Google Scholar 

  157. Nahrendorf M, Streif JU, Hiller KH, et al. Multimodal functional cardiac MRI in creatine kinase-deficient mice reveals subtle abnormalities in myocardial perfusion and mechanics. Am J Physiol Heart Circ Physiol 2006 Jun; 290 (6): H2516–21

    PubMed  CAS  Article  Google Scholar 

  158. Nahrendorf M, Wiesmann F, Hiller KH, et al. Serial cinemagnetic resonance imaging of left ventricular remodeling after myocardial infarction in rats. J Magn Reson Imaging 2001 Nov; 14 (5): 547–55

    PubMed  CAS  Article  Google Scholar 

  159. Liu Y, Sun L, Huan Y, et al. Application of bFGF and BDNF to improve angiogenesis and cardiac function. J Surg Res 2006 Nov; 136 (1): 85–91

    PubMed  CAS  Article  Google Scholar 

  160. Gumina RJ, O’Cochlain DF, Kurtz CE, et al. KATP channel knockout worsens myocardial calcium stress load in vivo and impairs recovery in stunned heart. Am J Physiol Heart Circ Physiol 2007 Apr; 292 (4): H1706–13

    PubMed  CAS  Article  Google Scholar 

  161. Whaley-Connell A, Govindarajan G, Habibi J, et al. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat. Am J Physiol Endocrinol Metab 2007 Jul; 293 (1): E355–63

    PubMed  CAS  Article  Google Scholar 

  162. Ibanez B, Vilahur G, Badimon JJ. Plaque progression and regression in atherothrombosis. J Thromb Haemost 2007 Jul; 5 Suppl. 1: 292–9

    PubMed  CAS  Article  Google Scholar 

  163. Schwartz SM, Galis ZS, Rosenfeld ME, et al. Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol 2007 Apr; 27 (4): 705–13

    PubMed  CAS  Article  Google Scholar 

  164. Spuentrup E, Botnar RM. Coronary magnetic resonance imaging: visualization of the vessel lumen and the vessel wall and molecular imaging of arteriothrombosis. Eur Radiol 2006 Jan; 16 (1): 1–14

    PubMed  Article  Google Scholar 

  165. Briley-Saebo KC, Mulder WJ, Mani V, et al. Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes. J Magn Reson Imaging 2007 Sep; 26 (3): 460–79

    PubMed  Article  Google Scholar 

  166. Barkhausen J, Ebert W, Heyer C, et al. Detection of atherosclerotic plaque with gadofluorine-enhanced magnetic resonance imaging. Circulation 2003 Aug; 108 (5): 605–9

    PubMed  CAS  Article  Google Scholar 

  167. Spuentrup E, Buecker A, Katoh M, et al. Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent. Circulation 2005 Mar; 111 (11): 1377–82

    PubMed  CAS  Article  Google Scholar 

  168. Sosnovik DE, Nahrendorf M, Deliolanis N, et al. Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo. Circulation 2007 Mar; 115 (11): 1384–91

    PubMed  Article  Google Scholar 

  169. Machold KP, Nell V, Stamm T, et al. Early rheumatoid arthritis. Curr Opin Rheumatol 2006 May; 18 (3): 282–8

    PubMed  CAS  Article  Google Scholar 

  170. Conaghan PG, O’Connor P, McGonagle D, et al. Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Arthritis Rheum 2003 Jan; 48 (1): 64–71

    PubMed  Article  Google Scholar 

  171. Wakefield RJ, Kong KO, Conaghan PG, et al. The role of ultrasonography and magnetic resonance imaging in early rheumatoid arthritis. Clin Exp Rheumatol 2003 Sep–Oct; 21 (5 Suppl. 31): S42–9

    PubMed  CAS  Google Scholar 

  172. Hunter DJ, Conaghan PG. Imaging outcomes and their role in determining outcomes in osteoarthritis and rheumatoid arthritis. Curr Opin Rheumatol 2006 Mar; 18 (2): 157–62

    PubMed  Article  Google Scholar 

  173. Brown AK, Quinn MA, Karim Z, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum 2006 Dec; 54 (12): 3761–73

    PubMed  CAS  Article  Google Scholar 

  174. Conaghan PG, McQueen FM, Peterfy CG, et al. The evidence for magnetic resonance imaging as an outcome measure in proof-of-concept rheumatoid arthritis studies. OMERACT 7 Special Interest Group. J Rheumatol 2005 Dec; 32 (12): 2465–9

    Google Scholar 

  175. Conaghan PG, Ejbjerg B, Lassere M, et al. A multicenter reliability study of extremity-magnetic resonance imaging in the longitudinal evaluation of rheumatoid arthritis. J Rheumatol 2007 Apr; 34 (4): 857–8

    PubMed  Google Scholar 

  176. Jarrett SJ, Conaghan PG, Sloan VS, et al. Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis. Arthritis Rheum 2006 May; 54 (5): 1410–4

    PubMed  CAS  Article  Google Scholar 

  177. Kothari M, Peterfy C. Rheumatoid and osteoarthritis: clinical applications. In: Beckmann N, editor. In vivo MR techniques in drug discovery and development. New York (NY): Taylor and Francis, 2006: 465–85

    Google Scholar 

  178. Østergaard M, McQueen FM, Bird P, et al. Magnetic resonance imaging in rheumatoid arthritis advances and research priorities. OMERACT 7 Special Interest Group. J Rheumatol 2005 Dec; 32 (12): 2462–4

    PubMed  Google Scholar 

  179. Wakefield RJ, O’Connor PJ, Conaghan PG, et al. Finger tendon disease in untreated early rheumatoid arthritis: a comparison of ultrasound and magnetic resonance imaging. Arthritis Rheum 2007 Oct 15; 57 (7): 1158–64

    PubMed  CAS  Article  Google Scholar 

  180. Crues JV, Shellock FG, Dardashti S, et al. Identification of wrist and metacarpophalangeal joint erosions using a portable magnetic resonance imaging system compared to conventional radiographs. J Rheumatol 2004 Apr; 31 (4): 676–85

    PubMed  Google Scholar 

  181. Chen TS, Crues 3rd JV, Ali M, et al. Magnetic resonance imaging is more sensitive than radiographs in detecting change in size of erosions in rheumatoid arthritis. J Rheumatol 2006 Oct; 33 (10): 1957–67

    PubMed  Google Scholar 

  182. Ghazinoor S, Crues 3rd JV, Crowley C. Low-field musculoskeletal MRI. J Magn Reson Imaging 2007 Feb; 25 (2): 234–44

    PubMed  Article  Google Scholar 

  183. Østergaard M, McQueen F, Bird P, et al. The OMERACT Magnetic Resonance Imaging Inflammatory Arthritis Group: advances and priorities. J Rheumatol 2007 Apr; 34 (4): 852–3

    PubMed  Google Scholar 

  184. Reece RJ, Kraan MC, Radjenovic A, et al. Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging. Arthritis Rheum 2002 Feb; 46 (2): 366–72

    PubMed  CAS  Article  Google Scholar 

  185. Hodgson RJ, O’Connor P, Moots R. MRI of rheumatoid arthritis image quantitation for the assessment of disease activity, progression and response to therapy. Rheumatology (Oxford) 2008 Jan; 47 (1): 13–21

    CAS  Article  Google Scholar 

  186. Gaffney K, Cookson J, Blades S, et al. Quantitative assessment of the rheumatoid synovial microvascular bed by gadolinium- DTPA enhanced magnetic resonance imaging. Ann Rheum Dis 1998 Mar; 57 (3): 152–7

    PubMed  CAS  Article  Google Scholar 

  187. Østergaard M, Stoltenberg M, Løvgreen-Nielsen P, et al. Quantification of synovitis by MRI: correlation between dynamic and static gadolinium-enhanced magnetic resonance imaging and microscopic and macroscopic signs of synovial inflammation. Magn Reson Imaging 1998 Sep; 16 (7): 743–54

    PubMed  Article  Google Scholar 

  188. Huang J, Stewart N, Crabbe J, et al. A 1-year follow-up study of dynamic magnetic resonance imaging in early rheumatoid arthritis reveals synovitis to be increased in shared epitope positive patients and predictive of erosions at 1 year. Rheu matology (Oxford) 2000 Apr; 39 (4): 407–16

    CAS  Article  Google Scholar 

  189. Palosaari K, Vuotila J, Takalo R, et al. Contrast-enhanced dynamic and static MRI correlates with quantitative 99mTc-labelled nanocolloid scintigraphy: study of early rheumatoid arthritis patients. Rheumatology (Oxford) 2004 Nov; 43 (11): 1364–73

    CAS  Article  Google Scholar 

  190. Tam LS, Griffith JF, Yu AB, et al. Rapid improvement in rheumatoid arthritis patients on combination of methotrexate infliximab: clinical and magnetic resonance imaging evaluation. Clin Rheumatol 2006 Jun; 26 (6): 941–6

    PubMed  Article  Google Scholar 

  191. Berger J, Voigt J, Seifert F, et al. Fluorescence imaging of rheumatoid arthritis in vivo using a fast flying-spot scanner. Biomedical Optics 2007 conference. Munich: SPIE, 6631–2

    Google Scholar 

  192. Fischer T, Gemeinhardt I, Wagner S, et al. Assessment of unspecific near-infrared dyes in laser-induced fluorescence imaging of experimental arthritis. Acad Radiol 2006 Jan; 13 (1): 4–13

    PubMed  Article  Google Scholar 

  193. Saidenberg-Kermanac HN, Leclercq F, Herscovici J, et al. High-resolution magnetic resonance imaging of knee inflammatory arthritis in mice. Clin Exp Rheumatol 2006 Mar–Apr; 24 (2): 216–7

    CAS  Google Scholar 

  194. Proulx ST, Kwok E, You Z, et al. Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography. Arthritis Rheum 2007 Dec; 56 (12): 4024–37

    PubMed  Article  Google Scholar 

  195. Beckmann N, Bruttel K, Mir A, et al. Noninvasive 3D MR microscopy as a tool in pharmacological research: application to a model of rheumatoid arthritis. Magn Reson Imaging 1995; 13 (7): 1013–7

    PubMed  CAS  Article  Google Scholar 

  196. Beckmann N, Bruttel K, Schuurman H, et al. Effects of Sandimmune Neoral on collagen-induced arthritis in DA rats: characterization by high resolution three-dimensional magnetic resonance imaging and by histology. J Magn Reson 1998 Mar; 131 (1): 8–16

    PubMed  CAS  Article  Google Scholar 

  197. Jacobson PB, Morgan SJ, Wilcox DM, et al. A new spin on an old model: in vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parameters and histopathology in the adjuvant arthritic rat. Arthritis Rheum 1999 Oct; 42 (10): 2060–73

    PubMed  CAS  Article  Google Scholar 

  198. Badger AM, Blake S, Kapadia R, et al. Disease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant- induced arthritis. Arthritis Rheum 2001 Jan; 44 (1): 128–37

    PubMed  CAS  Article  Google Scholar 

  199. Laurent D, Beckmann N. Rheumatoid and osteoarthritis: preclinical applications of in vivo MR. In: Beckmann N, editor. In vivo MR techniques in drug discovery and development. New York (NY): Taylor and Francis, 2006: 437–63

    Google Scholar 

  200. Lee SW, Greve JM, Leaffer D, et al. Early findings of smallanimal MRI and small-animal computed tomography correlate with histological changes in a rat model of rheumatoid arthritis. NMR Biomed 2008 Jun; 21 (5): 527–36

    PubMed  Article  Google Scholar 

  201. Dawson J, Gustard S, Beckmann N. High resolution 3D magnetic resonance imaging for the investigation of knee joint damage during the time-course of rabbit antigen-induced arthritis. Arthritis Rheum 1999 Jan; 42 (1): 119–28

    Article  Google Scholar 

  202. Doria AS, Noseworthy M, Oakden W, et al. Dynamic contrast-enhanced MRI quantification of synovium microcirculation in experimental arthritis. Am J Roentgenol 2006 Apr; 186 (4): 1165–71

    Article  Google Scholar 

  203. Lutz AM, Göpfert K, Jochum W, et al. USPIO-enhanced MR imaging for visualization of synovial hyperperfusion and detection of synovial macrophages: preliminary results in an experimental model of antigen-induced arthritis. J Magn Reson Imaging 2006 Sep; 24 (3): 657–66

    PubMed  Article  Google Scholar 

  204. Cutolo M. Macrophages as effectors of the immunoendocrinologic interactions in autoimmune rheumatic diseases. Ann NY Acad Sci 1999 Jun; 876: 32–41

    PubMed  CAS  Article  Google Scholar 

  205. Kinne RW, Brauer R, Stuhlmuller B, et al. Macrophages in rheumatoid arthritis. Arthritis Res 2000; 2 (3): 189–202

    PubMed  CAS  Article  Google Scholar 

  206. Beckmann N, Falk R, Zurbrügg S, et al. Macrophage infiltration into the rat knee detected by MRI in a model of antigeninduced arthritis. Magn Reson Med 2003 Jun; 49 (6): 1047–55

    PubMed  Article  Google Scholar 

  207. Simon GH, von Vopelius-Feldt J, Wendland MF, et al. MRI of arthritis: comparison of ultrasmall superparamagnetic iron oxide vs. Gd-DTPA. J Magn Reson Imaging 2006 May; 23 (5): 720–7

    PubMed  Article  Google Scholar 

  208. Weissleder R, Elizondo G, Wittenberg J, et al. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990 May; 175 (2): 489–93

    PubMed  CAS  Google Scholar 

  209. Hansch A, Frey O, Sauner D, et al. In vivo imaging of experimental arthritis with near-infrared fluorescence. Arthr Rheum 2004 Mar; 50 (3): 961–7

    Article  Google Scholar 

  210. Bischof RJ, Zafiropoulos D, Hamilton JA, et al. Exacerbation of acute inflammatory arthritis by the colony-stimulating factors CSF-1 and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation. Clin Exp Immunol 2000 Feb; 119 (2): 361–7

    PubMed  CAS  Article  Google Scholar 

  211. Chen WT, Mahmood U, Weissleder R, et al. Arthritis imaging using a near-infrared fluorescence folate-targeted probe. Arthritis Res Ther 2005; 7 (2): R310–7

    PubMed  CAS  Article  Google Scholar 

  212. Saborowski O, Simon GH, Raatschen HJ, et al. MR imaging of antigen-induced arthritis with a new, folate receptor-targeted contrast agent. Contrast Media Mot Imaging 2007 Mar; 2 (2): 72–81

    CAS  Article  Google Scholar 

  213. Wunder A, Tung CH, Muller-Ladner U, et al. In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. Arthritis Rheum 2004 Aug; 50 (8): 2459–65

    PubMed  CAS  Article  Google Scholar 

  214. Izmailova ES, Paz N, Alencar H, et al. Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis. Arthritis Rheum 2007 Jan; 56 (1): 117–28

    PubMed  CAS  Article  Google Scholar 

  215. Shaw LM. PENN biomarker core of the Alzheimer’s disease neuroimaging initiative. Neurosignals 2008 16 (1): 19–23

    PubMed  CAS  Article  Google Scholar 

  216. Kantarci K, Jack Jr CR. Quantitative magnetic resonance techniques as surrogate markers of Alzheimer’s disease. NeuroRx 2004 Apr; 1 (2): 196–205

    PubMed  Article  Google Scholar 

  217. Geuze E, Vermetten E, Bremner JD. MR-based in vivo hippocampal volumetrics: 2, findings in neuropsychiatric disorders. Mot Psychiatry 2005 Feb; 10 (2): 160–84

    CAS  Article  Google Scholar 

  218. Shi Y, Thompson PM, de Zubicaray GI, et al. Direct mapping of hippocampal surfaces with intrinsic shape context. Neuroimage 2007 Sep; 37 (3): 792–807

    PubMed  Article  Google Scholar 

  219. Vemuri P, Gunter JL, Senjem ML, et al. Alzheimer’s disease diagnosis in individual subjects using structural MR images: validation studies. Neuroimage 2008 Feb 1; 39 (3): 1186–97

    PubMed  Article  Google Scholar 

  220. Jack Jr CR, Dickson DW, Parisi JE, et al. Antemortem MRI findings correlate with hippocampal neuropathology in normal aging and dementia. Neurology 2002 Mar; 58 (5): 750–7

    PubMed  Article  Google Scholar 

  221. Silbert LC, Quinn JF, Moore MM, et al. Changes in premorbid brain volume predict Alzheimer’s disease pathology. Neurology 2003 Aug; 61 (4): 487–92

    PubMed  CAS  Article  Google Scholar 

  222. Bobinski M, de Leon MJ, Wegiel J, et al. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer’s disease. Neuroscience 2000; 95 (3): 721–5

    PubMed  CAS  Article  Google Scholar 

  223. Small SA. Imaging Alzheimer’s disease with MRI. In: Beckmann N, editor. In vivo MR techniques in drug discovery and development. New York (NY): Taylor and Francis, 2006: 111–22

    Google Scholar 

  224. Moreno H, Wu WE, Lee T, et al. Imaging the Abeta-related neurotoxicity of Alzheimer disease. Arch Neurol 2007 Oct; 64 (10): 1467–77

    PubMed  Article  Google Scholar 

  225. Whitwell JL, Jack Jr CR. Neuroimaging in dementia. Neurol Clin 2007 Aug; 25 (3): 843–57, viii

    PubMed  Article  Google Scholar 

  226. Bozzali M, Cherubini A. Diffusion tensor MRI to investigate dementias: a brief review. Magn Reson Imaging 2007 Jul; 25 (6): 969–77

    PubMed  Article  Google Scholar 

  227. Stahl R, Dietrich O, Teipel SJ, et al. White matter damage in Alzheimer disease and mild cognitive impairment: assessment with diffusion-tensor MR imaging and parallel imaging techniques. Radiology 2007 May; 243 (2): 483–92

    PubMed  Article  Google Scholar 

  228. van der Flier WM, van den Heuvel DMJ, Weverling-Rijnsburger AW, et al. Cognitive decline in AD and mild cognitive impairment is associated with global brain damage. Neurology 2002 Sep; 59 (6): 874–9

    Article  Google Scholar 

  229. Kantarci K. Magnetic resonance markers for early diagnosis and progression of Alzheimer’s disease. Expert Rev Neurother 2005 Sep; 5 (5): 663–70

    PubMed  CAS  Article  Google Scholar 

  230. Lehéricy S, Marjanska M, Mesrob L, et al. Magnetic resonance imaging of Alzheimer’s disease. Eur Radiol 2007 Feb; 17 (2): 347–62

    PubMed  Article  Google Scholar 

  231. Machulda M, Ward H, Borowski B, et al. Comparison of memory fMRI response among normal, MCI, and Alzheimer’s patients. Neurology 2003 Aug; 61 (4): 500–6

    PubMed  CAS  Article  Google Scholar 

  232. Sperling RA, Bates JF, Chua EF, et al. FMRI studies of associative encoding in young and elderly controls and mild Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2003 Jan; 74 (1): 44–50

    PubMed  CAS  Article  Google Scholar 

  233. Dickerson BC, Salat DH, Bates JF, et al. Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol 2004 Jul; 56 (1): 27–35

    PubMed  Article  Google Scholar 

  234. Dickerson BC, Salat DH, Greve DN, et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 2005; Aug; 65 (3): 404–11

    PubMed  CAS  Article  Google Scholar 

  235. Lin A, Ross BD, Harris K, et al. Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making. NeuroRx 2005 Apr; 2 (2): 197–214

    PubMed  Article  Google Scholar 

  236. Martin WR. MR spectroscopy in neurodegenerative disease. Mol Imaging Biol 2007 Jul–Aug; 9 (4): 196–203

    PubMed  Article  Google Scholar 

  237. Firbank MJ, Harrison RM, O’Brien JT. A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson’s disease. Dement Geriatr Cogn Disord 2002; 14 (2): 64–76

    PubMed  CAS  Article  Google Scholar 

  238. Jones RS, Waldman AD. 1H-MRS evaluation of metabolism in Alzheimer’s disease and vascular dementia. Neurol Res 2004 Jul; 26 (5): 488–95

    PubMed  CAS  Article  Google Scholar 

  239. Mueggler T. Magnetic resonance imaging and spectroscopy in targettransgenic mice modeling Alzheimer’s disease. In: Beckmann N, editor. In vivo MR techniques in drug discovery and development. New York (NY): Taylor and Francis, 2006: 95–110

    Google Scholar 

  240. Weiss C, Venkatasubramanian PN, Aguado AS, et al. Impaired eyeblink conditioning and decreased hippocampal volume in PDAPP V717F mice. Neurobiol Dis 2002 Dec; 11 (3): 425–33

    PubMed  CAS  Article  Google Scholar 

  241. Redwine JM, Kosofsky B, Jacobs RE, et al. Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis. Proc Natl Acad Sci U S A 2003 Feb; 100 (3): 1381–6

    PubMed  CAS  Article  Google Scholar 

  242. Mueggler T, Sturchler-Pierrat C, Baumann D, et al. Compromised hemodynamic response in amyloid precursor protein transgenic mice. J Neurosci 2002 Aug; 22 (16): 7218–24

    PubMed  CAS  Google Scholar 

  243. Mueggler T, Baumann D, Rausch M, et al. Age-dependent impairment of somatosensory response in the amyloid precursor protein 23 transgenic mouse model of Alzheimer’s disease. J Neurosci 2003 Sep; 23 (23): 8231–6

    PubMed  CAS  Google Scholar 

  244. Beckmann N, Schuler A, Mueggler T, et al. Age-dependent cerebrovascular abnormalities and blood flow disturbances in APP23 mice modeling Alzheimer’s disease. J Neurosci 2003 Sep; 23 (24): 8453–9

    PubMed  CAS  Google Scholar 

  245. Thal DR, Capetillo-Zarate E, Larionov S, et al. Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances. Neurobiol Aging 2008 Mar 20 [Epub ahead of print]; doi:10.1016/j.neurobiolaging.2008.01.017

    Google Scholar 

  246. Helpern JA, Lee SP, Falangola MF, et al. MRI assessment of neuropathology in a transgenic mouse model of Alzheimer’s disease. Magn Reson Med 2004 Apr; 51 (4): 794–8

    PubMed  Article  Google Scholar 

  247. Vanhoutte G, Dewachter I, Borghgraef P, et al. Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer’s disease. Magn Reson Med 2005 Mar; 53 (3): 607–13

    PubMed  CAS  Article  Google Scholar 

  248. Braakman N, Matysik J, van Duinen SG, et al. Longitudinal assessment of Alzheimer’s β-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging. J Magn Reson Imaging 2006 Sep; 24 (3): 530–6

    PubMed  Article  Google Scholar 

  249. El Tayara Nel T, Volk A, Dhenain M, et al. Transverse relaxa tion time reflects brain amyloidosis in young APP/PS1 trans genic mice. Magn Reson Med 2007 Jul; 58 (1): 179–84

    Article  Google Scholar 

  250. Falangola MF, Lee SP, Nixon RA, et al. Histological co-localization of iron in Abeta plaques of PS/APP transgenic mice. Neurochem Res 2005 Feb; 30 (2): 201–5

    PubMed  CAS  Article  Google Scholar 

  251. Marjanska M, Curran GL, Wengenack TM, et al. Monitoring disease progression in transgenic mouse models of Alzheimer’s disease with proton magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 2005 Aug; 102 (33): 11906–10

    PubMed  CAS  Article  Google Scholar 

  252. von Kienlin M, Kunnecke B, Metzger F, et al. Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span. Neurobiol Dis 2005 Feb; 18 (1): 32–9

    Article  CAS  Google Scholar 

  253. Dhenain M, Privat N, Duyckaerts C, et al. Senile plaques do not induce susceptibility effects in T2*-weighted MR microscopic images. NMR Biomed 2002 May; 15 (3): 197–203

    PubMed  Article  Google Scholar 

  254. Lee SP, Falangola MF, Nixon RA, et al. Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer’s disease using MR microscopy without contrast reagents. Magn Reson Med 2004 Sep; 52 (3): 538–44

    PubMed  Article  Google Scholar 

  255. Jack Jr CR, Wengenack TM, Reyes DA, et al. In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer’s transgenic mice. J Neurosci 2005 Oct; 25 (43): 10041–8

    PubMed  CAS  Article  Google Scholar 

  256. Poduslo JF, Wengenack TM, Curran GL, et al. Molecular target ing of Alzheimer’s amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol Dis 2002 Nov; 11 (2): 315–29

    PubMed  CAS  Article  Google Scholar 

  257. Wadghiri YZ, Sigurdsson EM, Sadowski M, et al. Detection of Alzheimer’s amyloid in transgenic mice using magnetic resonance microimaging. Magn Reson Med 2003 Aug; 50 (2): 293–302

    PubMed  CAS  Article  Google Scholar 

  258. Zhang J, Yarowsky P, Gordon MN, et al. Detection of amyloid plaques in mouse models of Alzheimer’s disease by magnetic resonance imaging. Magn Reson Med 2004 Mar; 51 (3): 452–7

    PubMed  Article  Google Scholar 

  259. Higuchi M, Iwata N, Matsuba Y, et al. 19F and 1H MRI detection of amyloid beta plaques in vivo. Nat Neurosci 2005 Apr; 8 (4): 527–33

    PubMed  CAS  Article  Google Scholar 

  260. Hintersteiner M, Enz A, Frey P, et al. In vivo detection of amyloid-β deposits by near-infrared imaging using an oxazine- derivative probe. Nat Biotechnol 2005 May; 23 (5): 577–83

    PubMed  CAS  Article  Google Scholar 

  261. Dixon D, Johnson GA, Cofer GP, et al. Magnetic resonance imaging (MRI): a new tool in experimental toxicologic pathology. Toxicol Pathol 1988; 16 (3): 386–91

    PubMed  CAS  Article  Google Scholar 

  262. Tengowski MW, Kotyk JJ. Risk identification and management: MRI as a research tool in toxicology studies of new chemical entities. Prog Drug Res 2005; 62: 257–78

    PubMed  CAS  Article  Google Scholar 

  263. Reid DG. MRI in pharmaceutical safety assessment. In: Beckmann N, editor. In vivo MR techniques in drug discovery and development. New York (NY): Taylor and Francis, 2006: 537–54

    Google Scholar 

  264. Ying X, Monticello TM. Modern imaging technologies in toxicologic pathology: an overview. Toxicol Pathol 2006; 34 (7): 815–26

    PubMed  Article  Google Scholar 

  265. Johnson GA, Thompson MB, Cofer GP, et al. Magnetic resonance imaging of hepatic neoplasms in the rat. Vet Pathol 1989 Jul; 26 (4): 303–8

    PubMed  CAS  Article  Google Scholar 

  266. Li X, Zhou XP, Guan YS, et al. Magnetic resonance imaging of hepatocellular carcinoma induced by diethylnitrosamine in Sprague-Dawley rats. Hepatobiliary Pancreat Dis Int 2005 Aug; 4 (3): 427–32

    PubMed  Google Scholar 

  267. Bachmann R, Kreft B, Dombrowski F, et al. Enhanced tumor detection in the presence of liver cirrhosis: experimental study on the diagnostic value of a superparamagnetic iron oxide MR imaging contrast agent (NSR 0430). J Magn Reson Imaging 1999 Feb; 9 (2): 251–6

    PubMed  CAS  Article  Google Scholar 

  268. Kish PE, Blaivas M, Strawderman M, et al. Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas. J Neurooncol 2001 Jul; 53 (3): 243–57

    PubMed  CAS  Article  Google Scholar 

  269. Single Nucleotide Polymorphism (SNP) Consortium [online]. Available from URL: http://snp.cshl.org [Accessed 2008 Jul 11]

  270. Zerhouni EA. Clinical research at a crossroads: the NIH roadmap. J Investig Med 2006 May; 54 (4): 171–3

    PubMed  Article  Google Scholar 

  271. Zerhouni EA. Translational research: moving discovery to practice Clin Pharmacol Ther 2007 Jan; 81 (1): 126–8

    PubMed  CAS  Article  Google Scholar 

  272. Zerhouni EA, Sanders CA, von Eschenbach AC. The Biomarkers Consortium: public and private sectors working in partnership to improve the public health. Oncologist 2007 Mar; 12 (3): 250–2

    PubMed  Article  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of this review.

Author information

Affiliations

  1. Institute for Electronic Structure and Laser, Foundation for Research and Technology-Hellas, Heraklion, Greece

    Jorge Ripoll

  2. Institute for Biological and Medical Imaging, Helmholtz Centre Munich and Technical University of Munich, Munich, Germany

    Vasilis Ntziachristos

  3. Novartis Institutes for BioMedical Research, Global Imaging Group, Novartis Campus, Forum 1, WSJ-386.2.09, Basel, DH-4056, Switzerland

    Catherine Cannet, Anna Louise Babin, Rainer Kneuer, Hans-Ulrich Gremlich & Nicolau Beckmann

  4. Sackler Institute of Pulmonary Pharmacology, King’s College, London, UK

    Anna Louise Babin

Authors
  1. Jorge Ripoll
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vasilis Ntziachristos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Catherine Cannet
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anna Louise Babin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rainer Kneuer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hans-Ulrich Gremlich
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nicolau Beckmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicolau Beckmann.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ripoll, J., Ntziachristos, V., Cannet, C. et al. Investigating Pharmacology In Vivo Using Magnetic Resonance and Optical Imaging. Drugs R D 9, 277–306 (2008). https://doi.org/10.2165/00126839-200809050-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200809050-00001

Keywords

  • Magnetic Resonance Imaging
  • Green Fluorescent Protein
  • Apparent Diffusion Coefficient
  • Capsaicin
  • Chemical Exchange Saturation Transfer